NEW YORK (GenomeWeb) – Enzo Biochem has sued Hologic again in federal court alleging patent infringement, Hologic said in its recently filed Form 10-Q. 

In the document filed with the US Securities and Exchange Commission, Hologic said that Enzo filed an additional lawsuit against it on March 27 in US District Court for the District of Delaware alleging certain Hologic molecular diagnostic products infringed US Patent No. 6,992,180, which is assigned to Enzo. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.